McNeil Ltd

Foundation Park, Roxborough Way, Maidenhead, Berks, SL6 3UG
Medical Information Direct Line: 01344 864042

Summary of Product Characteristics last updated on the eMC: 10/03/2008
SPC Anusol Cream


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

ANUSOL Cream


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

ANUSOL cream contains -

Zinc oxide Ph Eur

10.75 g

Bismith oxide

2.14 g

Balsam Peru Ph Eur

1.8 g


Go to top of the page
3. PHARMACEUTICAL FORM

A buff coloured cream


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

ANUSOL cream provides antiseptic, astringent and emollient properties which help to relieve discomfort associated with minor ano-rectal conditions.

ANUSOL cream also provides lubricating properties for use with suppositories.

Indicated for the symptomatic relief of uncomplicated internal and external haemorrhoids, pruritus ani, proctitis and fissures. Also indicated post-operatively in ano-rectal surgical procedures and after incision of thrombosed or sclerosed ano-rectal veins.


Go to top of the page
4.2 Posology and method of administration

Topical

Adults and elderly (over 65 years): apply to the affected area at night, in the morning and after each evacuation until the condition is controlled. Thoroughly cleanse the affected area, dry and apply cream. ANUSOL cream is prepared in a vanishing cream base and may be gently smoothed on to the affected area without the need to apply a gauze dressing. For internal conditions, use rectal nozzle provided. Remove the nozzle cap. Clean the nozzle after each use.

Not to be taken orally.

Children: Not Recommended.


Go to top of the page
4.3 Contraindications

Known hypersensitivity to any of the constituents.


Go to top of the page
4.4 Special warnings and precautions for use

None known.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

Whilst formal studies on the effect of this product during human pregnancy have not been conducted, there is no epidemiological evidence of adverse effect, either to the pregnant mother or foetus.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

Rarely, sensitivity reactions. Patients may occasionally experience transient burning on application, especially if the anoderm is not intact.


Go to top of the page
4.9 Overdose

Treatment of a large acute overdose should include gastric lavage, purgation with magnesium sulphate and complete bed rest. If necessary, apply oxygen and give general supportive measures.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

ANUSOL cream provides antiseptic, astringent and emollient properties which help to relieve discomfort associated with minor ano-rectal conditions. It also provides lubricating properties for use with suppositories.

Bismuth oxide is weakly astringent with supposed antiseptic properties and has a protective action on mucous membranes and raw surfaces. Zinc oxide is an astringent and mild antiseptic and probably owes its actions to the ability of the zinc ion to precipitate protein, but other mechanisms may be involved. Zinc oxide is also used to absorb skin moisture and decrease friction and discourage growth of certain bacteria. Balsam Peru has a very mild antiseptic action by virtue of its content of cinnamic and benzoic acids. It is believed to promote the growth of epithelial cells.


Go to top of the page
5.2 Pharmacokinetic properties

The active ingredients exert their therapeutic effect without being absorbed into the systemic circulation. These observations are supported by evidence from various studies and reviews.


Go to top of the page
5.3 Preclinical safety data

The active ingredients of ANUSOL are well known constituents of medicinal products and their safety profiles are well documented.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Glycerol monostearate Ph Eur

Liquid paraffin Ph Eur

Propylene glycol Ph Eur

Polysorbate 60 Ph Eur

Sorbitan stearate BP

Titanium dioxide Ph Eur

Methyl p-hydroxybenzoate Ph Eur

Propyl p-hydroxybenzoate Ph Eur

Purified water Ph Eur


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

3 years when stored in the original packaging.


Go to top of the page
6.4 Special precautions for storage

Store at a temperature not exceeding 25°C.


Go to top of the page
6.5 Nature and contents of container

Pack size 23g, 30g or 43g, externally printed and internally lacquered aluminium tube with plastic cap. A plastic nozzle with cap is also provided for internal application.


Go to top of the page
6.6 Special precautions for disposal and other handling

No special requirements.


Go to top of the page
Administrative Data

Go to top of the page
7. MARKETING AUTHORISATION HOLDER

McNeil Products Limited

Foundation Park

Roxborough Way

Maidenhead

Berkshire SL6 3UG

United Kingdom


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 15513/0041


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

15 September 1997


Go to top of the page
10. DATE OF REVISION OF THE TEXT

25 February 2008



More information about this product

Link to this document from your website: http://emc.medicines.org.uk/medicine/7159/SPC/Anusol Cream/

Active Ingredients/Generics

 
   zinc oxide
   bismuth oxide
   bismuth subgallate


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk